E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/20/2008 in the Prospect News PIPE Daily.

New Issue: Corcept Therapeutics reveals further details on $25.27 million private placement of units

By Devika Patel

Knoxville, Tenn., March 20 - Corcept Therapeutics Inc. gave more details of a planned $25.27 million private placement of stock and warrants in an 8-K filed Thursday with the Securities and Exchange Commission. The deal was announced on March 17.

The company will sell 8,923,210 shares at $2.77 apiece for $24.72 million. Investors also will buy warrants for 4,461,599 common shares at $0.125 per warrant for $557,700. Each warrant will be exercisable at $2.77 for seven years.

The investors are being led by Longitude Capital Management Co., LLP and also include Paperboy Ventures LLC, Sutter Hill Ventures and Alta Partners, LLP, and various venture capital firms, entities and other accredited investors.

Settlement is expected March 25.

Proceeds will be used to conduct the company's next Phase 3 clinical trial evaluating CORLUX(r) for the treatment of the psychotic features of psychotic depression, which will begin enrollment shortly, to conduct a clinical trial for CORLUX for the treatment of Cushing's syndrome, to conduct clinical trials to evaluate the management of weight gain induced by antipsychotic medications, to continue development of the company's proprietary, selective GR-II antagonists and for general corporate purposes, including working capital.

Menlo Park, Calif.-based Corcept is a pharmaceutical company engaged in the development of medications for the treatment of severe psychiatric and metabolic diseases.

Issuer:Corcept Therapeutics Inc.
Issue:Common shares, warrants
Amount:$25,274,991.575
Investors:Longitude Capital Management Co., LLP (lead), Paperboy Ventures LLC, Sutter Hill Ventures and Alta Partners, LLP
Pricing date:March 14
Announcement date:March 17
Settlement date:March 25
Stock symbol:Nasdaq: CORT
Stock price:$2.77 at close March 14
Shares
Amount:$24,717,291.70
Shares:8,923,210
Price:$2.77
Warrants
Amount:$557,699.875
Warrants:For 4,461,599 shares
Warrant expiration:Seven years
Warrant price:$0.125
Warrant strike price:$2.77

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.